A different kinetic profile of ochratoxin A in mature male rats

Food and Chemical Toxicology

Volumn 47, Issue 8, 2009, Pages 1921-1927

  Vettorazzi, A ^a   Gonzalez Penas E ^b   Troconiz I F ^b   Arbillaga, L ^a   Corcuera, L A ^a   Gil, A G ^a   Lopez de Cerain A ^a  

^a Faculty of Pharmacy   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Age; Male and female F344 rats; Ochratoxin A; Plasma; Simulation; Toxicokinetic population approach

Indexed keywords

OCHRATOXIN;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; BODY WEIGHT; CARCINOGEN TESTING; CONTROLLED STUDY; FEMALE; FISCHER 344 RAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LONG TERM EXPOSURE; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CLEARANCE; PLASMA HALF LIFE; PROCESS MODEL; RAT; SEX DIFFERENCE; TOXICOKINETICS;

AGING; ANIMALS; BODY WEIGHT; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; MALE; OCHRATOXINS; RATS; RATS, INBRED F344; SEX CHARACTERISTICS; SPECTROMETRY, FLUORESCENCE;

RATTUS; RODENTIA;

EID: 68649088289     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.05.003     Document Type: Article

References (32)

1. Aoudia N., Tangni E.K., and Larondelle Y. Distribution of ochratoxin A in plasma and tissues of rats fed a naturally contaminated diet amended with micronized wheat fibres: Effectiveness of mycotoxin sequestering activity. Food Chem. Toxicol. 46 (2008) 871-878
2. Beal, S.L., Sheiner, L.B., Boeckmann, A.J., 1989-2006. NONMEM User's Guides, Icon Developemnt Solutions, Ellicot City, MA.
3. Belmadani A., Tramu G., Betbeder A.M., Steyn P.S., and Creppy E.E. Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain. Arch. Toxicol. 72 (1998) 656-662
4. Bendele A.M., Carlton W.W., Krogh P., and Lillehoj E.B. Ochratoxin A carcinogenesis in the (C57BL/6J X C3H)F1 mouse. J. Natl. Cancer Inst. 75 (1985) 733-742
5. Castegnaro M., Mohr U., Pfohl-Leszkowicz A., Esteve J., Steinmann J., Tillmann T., Michelon J., and Bartsch H. Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 77 (1998) 70-75
6. Diehl K.H., Hull R., Morton D., Pfister R., Rabemampianina Y., Smith D., Vidal J.M., and van de Vorstenbosch C. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 21 (2001) 15-23
7. Dietrich D.R., Heussner A.H., and O'Brien E. Ochratoxin A: Comparative pharmacokinetics and toxicological implications (experimental and domestic animals and humans). Food Addit. Contam. 22 Suppl. 1 (2005) 45-52
8. Dortant P.M., Peters-Volleberg G.W., Van Loveren H., Marquardt R.R., and Speijers G.J. Age-related differences in the toxicity of ochratoxin A in female rats. Food Chem. Toxicol. 39 (2001) 55-65
9. European Food Safety Authority. Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food. EFSA J. 365 (2006) 1-56 Adopted on 4 April 2006
10. Galtier P., Charpenteau J.L., Alvinerie M., and Labouche C. The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration. Drug Metab. Dispos. 7 (1979) 429-434
11. Galtier P. Pharmacokinetics of ochratoxin A in animals. IARC Sci. Publ. 115 (1991) 187-200
12. Hagelberg S., Hult K., and Fuchs R. Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 9 (1989) 91-96
13. Harlan specifications. Fisher 344. .
14. IARC, 1993. Ochratoxin A. Some Naturally Occurring Substances: Food items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 56. Lyon, pp. 489-521.
15. IPCS. Selected Mycotoxins: Ochratoxins, Trichothecenes, Ergot. Environmental Health Criteria 105 (1990), WHO, Geneva
16. Karlsson, M.O., Holford, N.H., 2008. A Tutorial on Visual Predictive Checks. (p. 17 2008= Abstract 1434 ).
17. Kuiper-Goodman T., and Scott P.M. Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 2 (1989) 179-248
18. Li S., Marquardt R.R., Frohlich A.A., Vitti T.G., and Crow G. Pharmacokinetics of ochratoxin A and its metabolites in rats. Toxicol. Appl. Pharmacol. 145 (1997) 82-90
19. Mally A., Volkel W., Amberg A., Kurz M., Wanek P., Eder E., Hard G., and Dekant W. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats. Chem. Res. Toxicol. 18 (2005) 1242-1252
20. Mantle P., and Nagy J. Binding of a ochratoxin A to a urinary globulin: A new concept to account for gender difference in rat nephrocarcinogenic responses. Int. J. Mol. Sci. 9 (2008) 719-735
21. Mantle P., Kulinskaya E., and Nestler S. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit. Contam. 22 Suppl. 1 (2005) 58-64
22. Mantle P. Interpretation of the pharmacokinetics of ochratoxin A in blood plasma of rats, during and after acute or chronic ingestion. Food Chem. Toxicol. 46 (2008) 1808-1816
23. Marin-Kuan M., Nestler S., Verguet C., Bezencon C., Piguet D., Mansourian R., Holzwarth J., Grigorov M., Delatour T., Mantle P., Cavin C., and Schilter B. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat. Toxicol. Sci. 89 (2006) 120-134
24. National Toxicology Program (NTP). Toxicology and carcinogenesis studies of ochratoxin A (CAS No 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 358 (1989) 1-142
25. OECD Guideline for testing of chemicals, Number 417. Adoped 4 April 1984. Toxicokinetics.
26. Pfohl-Leszkowicz A., Petkova-Bocharova T., Chernozemsky I.N., and Castegnaro M. Balkan endemic nephropathy and associated urinary tract tumours: A review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 19 (2002) 282-302
27. Ringot D., Chango A., Schneider Y.J., and Larondelle Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 159 (2006) 18-46
28. Rowland M., and Tozer T.N. Distribution Kinetics in Clinical Pharmacokinetics. Concepts and Applications. third ed. (1995), Williams and Wilkins, PA, USA p. 318
29. Sava V., Reunova O., Velasquez A., Harbison R., and Sanchez-Ramos J. Acute neurotoxic effects of the fungal metabolite ochratoxin-A. Neurotoxicology 27 (2006) 82-92
30. Suzuki S., Satoh T., and Yamazaki M. The pharmacokinetics of ochratoxin A in rats. Jpn. J. Pharmacol. 27 (1977) 735-744
31. Vettorazzi A., Gonzalez-Penas E., Arbillaga L., Corcuera L.A., and Lopez de Cerain A. Simple high-performance liquid chromatography-fluorescence detection method for plasma, kidney and liver of rat as a tool for toxicology studies. J. Chromatogr. A 1215 (2008) 100-106
32. Zepnik H., Völkel W., and Dekant W. Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol. Appl. Pharmacol. 192 (2003) 36-44